ArticleBJC reports2026

Remarkable response of metaplastic breast cancer to a novel targeted AKT inhibitor TAS-117 in a Cowden syndrome patient: a case report.

Eva Godina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.